Cost-effectiveness analyses and modelling the lifetime costs and benefits of health-behaviour interventions

Graves, N., McKinnon, L., Reeves, M., Scuffman, P., Gordon, L. and Eakin, E. (2006) Cost-effectiveness analyses and modelling the lifetime costs and benefits of health-behaviour interventions. Chronic Illness, 2 2: 97-107. doi:10.1177/17423953060020020501


Author Graves, N.
McKinnon, L.
Reeves, M.
Scuffman, P.
Gordon, L.
Eakin, E.
Title Cost-effectiveness analyses and modelling the lifetime costs and benefits of health-behaviour interventions
Journal name Chronic Illness   Check publisher's open access policy
ISSN 1742-3953
Publication date 2006-06-01
Sub-type Article (original research)
DOI 10.1177/17423953060020020501
Open Access Status Not Open Access
Volume 2
Issue 2
Start page 97
End page 107
Total pages 11
Editor C. Dowrick
Place of publication London
Publisher Maney Publishing
Language eng
Subject C1
320204 Immunogenetics
730219 Behaviour and health
1107 Immunology
Abstract To assess the usage of cost-utility analysis (CUA) in oral health interventions and to evaluate the methods used and the reporting quality of CUA in publications on oral health interventions.
Formatted abstract
Background: We describe an approach to estimating the cost-effectiveness of an intervention that changes health behaviour. The method captures the lifetime costs and benefits incurred by participants in an ongoing cluster-randomized controlled trial of an intervention that aims to change health behaviour. The existing literature only captures short-term economic and health outcomes.

Methods: We develop a state-transition Markov model of how individuals move between different health behaviour states over time. We simulate hypothetical data to describe the costs and health benefits of the intervention, illustrate how the data collected in the ongoing randomized controlled trial can be used and demonstrate how incremental cost-effectiveness ratios are estimated.

Results: On the basis of the simulated (i.e. hypothetical) data, we estimate the cost per quality-adjusted life year. The estimate reflects the lifetime health and economic consequences of the intervention.

Discussion: The method used for the cost-effectiveness analysis described in this paper is appropriate for investigating whether interventions that change health behaviour in relation to chronic diseases represent good value for money as compared to alternative uses of scarce healthcare resources.
Keyword Cost-effectiveness
Markov chain
Patient compliance
Health behaviour
Quality-adjusted life years
Q-Index Code C1
Institutional Status UQ

 
Versions
Version Filter Type
Citation counts: Scopus Citation Count Cited 15 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Wed, 15 Aug 2007, 20:24:54 EST